We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.65B
AUM Growth
+$399M
Cap. Flow
+$23.1M
Cap. Flow %
0.63%
Top 10 Hldgs %
29.99%
Holding
549
New
63
Increased
188
Reduced
161
Closed
15

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$21.6M
2
TAIL icon
Cambria Tail Risk ETF
TAIL
+$11.3M
3
KEYS icon
Keysight
KEYS
+$4.77M
4
APD icon
Air Products & Chemicals
APD
+$3.48M
5
FISV
Fiserv Inc
FISV
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 15.58%
3 Financials 11.72%
4 Consumer Staples 9.52%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIF
151
DELISTED
Tiffany & Co.
TIF
$2.36M 0.06%
17,936
-800
-4% -$102K
DVY icon
152
iShares Select Dividend ETF
DVY
$23.6B
$2.36M 0.06%
24,510
+401
+2% +$36.4K
PNC icon
153
PNC Financial Services
PNC
$99.2B
$2.35M 0.06%
15,752
+18
+0.1% +$2.3K
CMI icon
154
Cummins
CMI
$87.3B
$2.35M 0.06%
10,331
-89
-0.9% -$20K
NOC icon
155
Northrop Grumman
NOC
$76B
$2.33M 0.06%
7,639
+150
+2% +$45.9K
VTI icon
156
Vanguard Morningstar Total Stock Market ETF
VTI
$657B
$2.3M 0.06%
11,821
+755
+7% +$138K
AME icon
157
Ametek
AME
$55B
$2.29M 0.06%
18,944
+150
+0.8% +$16.9K
ITOT icon
158
iShares Core S&P Total US Stock Market ETF
ITOT
$93.8B
$2.27M 0.06%
26,351
BAC icon
159
Bank of America
BAC
$433B
$2.26M 0.06%
74,522
+2,386
+3% +$64K
IWF icon
160
iShares Russell 1000 Growth ETF
IWF
$120B
$2.24M 0.06%
37,228
-500
-1% -$28.5K
QYLD icon
161
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.06B
$2.24M 0.06%
98,330
+80,770
+460% +$1.79M
AYX
162
DELISTED
Alteryx Inc
AYX
$2.19M 0.06%
18,005
-1,275
-7% -$161K
PHG icon
163
Philips
PHG
$25.8B
$2.19M 0.06%
49,751
-802
-2% -$33.1K
FITB
164
Fifth Third Bancorp
FITB
$51.3B
$2.1M 0.06%
76,345
-895
-1% -$22.6K
CVS icon
165
CVS Health
CVS
$134B
$2.04M 0.06%
29,804
-2,216
-7% -$144K
EVRG icon
166
Evergy
EVRG
$19.2B
$2M 0.05%
36,022
+1,665
+5% +$91.4K
AZN icon
167
AstraZeneca
AZN
$266B
$1.97M 0.05%
19,720
+260
+1% +$27.5K
RNLX
168
DELISTED
Renalytix plc American Depositary Shares
RNLX
$1.96M 0.05%
122,450
+8,250
+7% +$102K
CPRT icon
169
Copart
CPRT
$27.4B
$1.95M 0.05%
61,360
AON icon
170
Aon
AON
$78.3B
$1.95M 0.05%
9,213
MDT icon
171
Medtronic
MDT
$110B
$1.88M 0.05%
16,078
+166
+1% +$18.3K
DXJ icon
172
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
$1.84M 0.05%
33,900
-5,000
-13% -$258K
WSM icon
173
Williams-Sonoma
WSM
$27.5B
$1.83M 0.05%
35,870
EQR icon
174
Equity Residential
EQR
$25.2B
$1.8M 0.05%
30,433
-909
-3% -$51.4K
BNY
175
Bank of New York Mellon
BNY
$106B
$1.8M 0.05%
42,451
-3,801
-8% -$146K

Similar funds

Gofen & Glossberg's Q4 2020 Portfolio in Review

As of Q4 2020, Gofen & Glossberg held 549 positions worth $3.65B, up 12% from $3.25B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Gofen & Glossberg's Q4 2020 filing shows 63 new, 188 increased, 161 reduced and 15 closed positions. Its largest new stake was Constellation Brands: 12,448 shares worth $2.73M. The largest sale was Unilever NV New York Registry Shares, an estimated $21.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q4 2020 buy was Constellation Brands: 12,448 shares worth $2.73M.
  • Gofen & Glossberg added most to Unilever in Q4 2020, an estimated $21.6M increase.
  • Gofen & Glossberg's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $3.52M.
  • Gofen & Glossberg fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $21.5M.
  • Gofen & Glossberg's ten largest holdings make up 30% of its $3.65B portfolio in Q4 2020.
  • Gofen & Glossberg opened 63 new positions and closed 15 in Q4 2020.
  • Gofen & Glossberg's portfolio value rose 12% quarter-over-quarter to $3.65B.

Based on Gofen & Glossberg's 13F filing for Q4 2020, filed 15 Jan 2021.